These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26672759)

  • 1. Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.
    Kaltsatou A; Fotiou D; Tsiptsios D; Orologas A
    BBA Clin; 2015 Jun; 3():299-303. PubMed ID: 26672759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the cholinergic hypothesis in Alzheimer's disease with neuropsychological methods.
    Fotiou D; Kaltsatou A; Tsiptsios D; Nakou M
    Aging Clin Exp Res; 2015 Oct; 27(5):727-33. PubMed ID: 25749905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pupillometric findings in patients with Parkinson's disease and cognitive disorder.
    Stergiou V; Fotiou D; Tsiptsios D; Haidich B; Nakou M; Giantselidis C; Karlovasitou A
    Int J Psychophysiol; 2009 May; 72(2):97-101. PubMed ID: 19047001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic deficiency in Alzheimer's and Parkinson's disease: evaluation with pupillometry.
    Fotiou DF; Stergiou V; Tsiptsios D; Lithari C; Nakou M; Karlovasitou A
    Int J Psychophysiol; 2009 Aug; 73(2):143-9. PubMed ID: 19414041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects.
    Tucker DM; Roeltgen DP; Wann PD; Wertheimer RI
    Neurology; 1988 Aug; 38(8):1173-7. PubMed ID: 3399065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pupil mobility in patients with myasthenia gravis.
    Tsiptsios D; Fotiou DF; Haidich AB; Brozou GC; Nakou M; Giantselidis C; Karlovasitou A; Fotiou F
    Electromyogr Clin Neurophysiol; 2008; 48(5):209-18. PubMed ID: 18754530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age on pupillary light reflex: evaluation of pupil mobility for clinical practice and research.
    Fotiou DF; Brozou CG; Tsiptsios DJ; Fotiou A; Kabitsi A; Nakou M; Giantselidis C; Goula A
    Electromyogr Clin Neurophysiol; 2007; 47(1):11-22. PubMed ID: 17375877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of cognitive impairment in elderly myasthenia gravis patients.
    Marra C; Marsili F; Quaranta D; Evoli A
    Muscle Nerve; 2009 Dec; 40(6):952-9. PubMed ID: 19768771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studying the relationship between clinical features and mental health among late-onset myasthenia gravis patients.
    Yu L; Qiu L; Ran H; Ma Q; Lu YR; Liu WB
    World J Psychiatry; 2022 Mar; 12(3):470-482. PubMed ID: 35433329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological function before and after plasma exchange in myasthenia gravis.
    Iwasaki Y; Kinoshita M; Ikeda K; Shiojima T; Kurihara T
    J Neurol Sci; 1993 Feb; 114(2):223-6. PubMed ID: 8445405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological performance in patients with myasthenia gravis].
    Eizaguirre MB; Aguirre F; Yastremiz C; Vanotti S; Villa A
    Medicina (B Aires); 2017; 77(2):117-120. PubMed ID: 28463217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.
    Glennerster A; Palace J; Warburton D; Oxbury S; Newsom-Davis J
    Neurology; 1996 Apr; 46(4):1138-42. PubMed ID: 8780106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction in myasthenia gravis.
    Iwasaki Y; Kinoshita M; Ikeda K; Takamiya K; Shiojima T
    Int J Neurosci; 1990 Sep; 54(1-2):29-33. PubMed ID: 2265963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of central functional cholinergic deficits in myasthenia gravis.
    Lewis SW; Ron MA; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):258-61. PubMed ID: 2703842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupillometric characteristics in patients with choroidal neovascularization due to age-related macular degeneration.
    Brozou C; Fotiou D; Androudi S; Theodoridou E; Giantselidis C; Alexandridis A; Brazitikos P
    Eur J Ophthalmol; 2009; 19(2):254-62. PubMed ID: 19253243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is overactive bladder a nervous or bladder disorder? Autonomic imaging in patients with overactive bladder via dynamic pupillometry.
    Aydogmus Y; Uzun S; Gundogan FC; Ulas UH; Ebiloglu T; Goktas MT
    World J Urol; 2017 Mar; 35(3):467-472. PubMed ID: 27311587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis and sleep].
    Stepansky R; Zeitlhofer J
    Wien Klin Wochenschr; 2001 Apr; 113(7-8):285-7. PubMed ID: 11383390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-Induced Pupillary Responses in Alzheimer's Disease.
    Chougule PS; Najjar RP; Finkelstein MT; Kandiah N; Milea D
    Front Neurol; 2019; 10():360. PubMed ID: 31031692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal sympathetic hyper-reactivity in patients with myasthenia gravis: a prospective study.
    Shukla G; Gupta S; Goyal V; Singh S; Srivastava A; Behari M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):179-86. PubMed ID: 22676958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.